Hemispherx Biopharma Inc (NYSE American:HEB)

0.3133
Delayed Data
As of May 25
 -0.0018 / -0.57%
Today’s Change
0.28
Today|||52-Week Range
0.74
-9.45%
Year-to-Date
No recent news for Hemispherx Biopharma Inc.

Today’s Trading

Previous close0.32
Today’s open0.31
Day’s range0.31 - 0.32
Volume239,818
Average volume (3 months)603,510
Market cap$11.6M
Data as of 8:00pm ET, 05/25/2018

Growth & Valuation

Earnings growth (last year)+14.71%
Earnings growth (this year)--
Earnings growth (next 5 years)+35.00%
Revenue growth (last year)+375.00%
P/E ratioNM
Price/Sales22.70
Price/Book1.13

Competitors

 Today’s
change
Today’s
% change
ARGSArgos Therapeutics I...-0.01-5.03%
ITUSITUS Corp+0.03+0.84%
----
SBOTStellar Biotechnolog...-0.17-7.73%
Data as of 4:00pm ET, 05/25/2018

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$437.0K
Annual profit (last year)-$8.3M
Net profit margin-1,889.93%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Vice Chairman, President &
CEO
Thomas Kenwood Equels
Senior Vice President-
Operations
Wayne S. Springate
Corporate headquarters
Orlando, Florida

Forecasts